171 related articles for article (PubMed ID: 22350063)
21. Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
Gunda DW; Kilonzo SB; Kamugisha E; Rauya EZ; Mpondo BC
BMC Res Notes; 2017 Jun; 10(1):197. PubMed ID: 28595630
[TBL] [Abstract][Full Text] [Related]
22. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
[TBL] [Abstract][Full Text] [Related]
23. Initial suboptimal CD4 reconstitution with antiretroviral therapy despite full viral suppression in a cohort of HIV-infected patients in Senegal.
Batista G; Buvé A; Ngom Gueye NF; Manga NM; Diop MN; Ndiaye K; Thiam A; Ly F; Diallo A; Ndour CT; Seydi M
Med Mal Infect; 2015 Jun; 45(6):199-206. PubMed ID: 25907261
[TBL] [Abstract][Full Text] [Related]
24. Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital.
Saavedra A; Campinha-Bacote N; Hajjar M; Kenu E; Gillani FS; Obo-Akwa A; Lartey M; Kwara A
Pan Afr Med J; 2017; 27():48. PubMed ID: 28819470
[TBL] [Abstract][Full Text] [Related]
25. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/King county adult/adolescent spectrum of HIV-related diseases project.
Uhlenkott MC; Buskin SE; Kahle EM; Barash E; Aboulafia DM
Am J Med Sci; 2008 Sep; 336(3):217-23. PubMed ID: 18794615
[TBL] [Abstract][Full Text] [Related]
26. Neoplasms-associated deaths in HIV-1 infected and non-infected patients in Bahia, Brazil.
Marques M; Luz E; Leal M; Oliveira JV; Patrício R; Netto EM; Brites C
Cancer Epidemiol; 2018 Jun; 54():133-136. PubMed ID: 29727806
[TBL] [Abstract][Full Text] [Related]
27. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.
Cohen MH; French AL; Benning L; Kovacs A; Anastos K; Young M; Minkoff H; Hessol NA
Am J Med; 2002 Aug; 113(2):91-8. PubMed ID: 12133746
[TBL] [Abstract][Full Text] [Related]
28. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
29. [Survival in HIV-1 patients receiving antiretroviral therapy in Morocco].
Titou H; Baba N; Kasouati J; Oumakir S; Frikh R; Boui M; Hjira N
Rev Epidemiol Sante Publique; 2018 Sep; 66(5):311-316. PubMed ID: 30177238
[TBL] [Abstract][Full Text] [Related]
30. [Central Neurological Diagnosis in Patients Infected with HIV in the Infectious Diseases Unit of University Hospital of Casablanca, Morocco].
El Fane M; Sodqi M; Lamdini H; Marih L; Lahsen AO; Chakib A; El Filali KM
Bull Soc Pathol Exot; 2018; 111(1):24-30. PubMed ID: 30763499
[TBL] [Abstract][Full Text] [Related]
31. Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy.
Trickey A; May MT; Vehreschild J; Obel N; Gill MJ; Crane H; Boesecke C; Samji H; Grabar S; Cazanave C; Cavassini M; Shepherd L; d'Arminio Monforte A; Smit C; Saag M; Lampe F; Hernando V; Montero M; Zangerle R; Justice AC; Sterling T; Miro J; Ingle S; Sterne JA;
PLoS One; 2016; 11(8):e0160460. PubMed ID: 27525413
[TBL] [Abstract][Full Text] [Related]
32. [Epidemiological and clinical characteristics of HIV/AIDS patients followed-up in Cappadocia region: 18 years experience].
Alp E; Bozkurt I; Doğanay M
Mikrobiyol Bul; 2011 Jan; 45(1):125-36. PubMed ID: 21341167
[TBL] [Abstract][Full Text] [Related]
33. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
Ingle SM; May MT; Gill MJ; Mugavero MJ; Lewden C; Abgrall S; Fätkenheuer G; Reiss P; Saag MS; Manzardo C; Grabar S; Bruyand M; Moore D; Mocroft A; Sterling TR; D'Arminio Monforte A; Hernando V; Teira R; Guest J; Cavassini M; Crane HM; Sterne JA;
Clin Infect Dis; 2014 Jul; 59(2):287-97. PubMed ID: 24771333
[TBL] [Abstract][Full Text] [Related]
34. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.
Kowalska JD; Reekie J; Mocroft A; Reiss P; Ledergerber B; Gatell J; d'Arminio Monforte A; Phillips A; Lundgren JD; Kirk O;
AIDS; 2012 Jan; 26(3):315-23. PubMed ID: 22112597
[TBL] [Abstract][Full Text] [Related]
35. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
36. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
[TBL] [Abstract][Full Text] [Related]
37. Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan.
Deng SC; Chen MY; Hsieh SM; Sheng WH; Hsiao CF; Hung CC; Chang SC
J Microbiol Immunol Infect; 2003 Mar; 36(1):10-4. PubMed ID: 12741726
[TBL] [Abstract][Full Text] [Related]
38. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
[TBL] [Abstract][Full Text] [Related]
40. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
